• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
Gynesonics

Gynesonics

Advancing technology. Improving women's lives.

  • Our Company
    • About Us
    • Careers
    • Compliance and Quality
  • Our People
    • Management
    • Board of Directors
    • Investors
  • Our Technology
    • The Sonata System
    • Indications and Safety
    • Instructions for Use
    • Request for Medical or Scientific Information
  • Our News
    • Press Releases
    • In the News
    • Publications
  • Contact Us

Press Releases

Gynesonics names James Sparks Vice President of Manufacturing

March 30, 2017

Respected Leader in Medical Device Manufacturing and Engineering Management Redwood City, CA – March 30, 2017 - Gynesonics, a women’s healthcare company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of symptomatic

Data from Sonata Technology Platform Featured in Presentations at AAGL Global Congress in Orlando

November 10, 2016

First Health Economic Outcomes Research with Sonata Treatment to be Presented Redwood City, CA – Nov 10, 2016 - Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions, today announced that its Sonata® System

Sonata Technology Platform Featured in Presentations at Upcoming Congress of the German Society of Obstetrics and Gynecology (DGGG)

October 19, 2016

Increasing Body of Evidence Further Demonstrates Compelling Outcomes Redwood City, CA – October 19, 2016 - Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions, today announced that its Sonata® System

Gynesonics Announces Early Completion of Enrollment in the SONATA FDA Clinical Trial for Incision Free Treatment of Symptomatic Uterine Fibroids

October 18, 2016

Company Expects to Submit Trial Results to FDA in Fourth Quarter of 2017 Redwood City, CA – October 18, 2016 - Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for treatment of benign uterine conditions, today announced the completion of

Gynesonics Names Jiayu Chen, PhD, Vice President, Engineering and Advanced Technologies

May 5, 2016

Redwood City, CA – May 5, 2016 - Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that medical device executive Jiayu Chen, Ph.D., has been named Vice President of Engineering and

Gynesonics Names Taraneh G. Farazi Vice President, Clinical Affairs

February 25, 2016

Accomplished Clinical Affairs Executive to Lead Clinical Research Initiatives and Programs Redwood City, CA – February 25, 2016 - Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that veteran

Gynesonics Completes $46 Million Equity Financing

November 17, 2015

Novit Ventures LP Participates in Latest Round Redwood City, CA - November 17, 2015 - Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced $2.9 million of additional equity financing, increasing the

Gynesonics Technology Featured in Five Presentations at 2015 American Association of Gynecologic Laparoscopists Global Congress

November 12, 2015

Presentation on Early Clinical Response to Sonata™ System Selected as Best Abstract In New Instrumentation/Technology Category Redwood City, CA—November 12, 2015 – Gynesonics, Inc., a women’s health technology company focused on the development and commercialization of breakthrough products

  • « Previous Page
  • Page 1
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Next Page »

Primary Sidebar

  • Privacy Notice
  • Cookie Notice
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information

© Copyright 2025 Gynesonics · All Rights Reserved · WS 05198 Rev. L

  • Privacy Notice
  • Cookie Notice
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information